Within the tumor-infiltrating CD4_4 cluster, we observed increased expression of the Th1 driver TBX21 (T-bet), activation marker LAG3 and NR4A2 and cytokine expression (Fig. 4c). The gene discussed is NR4A2; the disease is neoplasm.